ANXA1 and Alzheimer disease: This idea is supported by the actions of ANXA1 in promoting non-phlogistic (non-inflammatory) microglial phagocytosis, even in the face of inflammatory challenge with Aβ [83], and is further supported by the recent identification of a single nucleotide polymorphism in the regulatory region of ANXA1 that associates with susceptibility to AD [102].